AU4880901A - Novel insulin/igf/relaxin family polypeptides and dnas thereof - Google Patents

Novel insulin/igf/relaxin family polypeptides and dnas thereof

Info

Publication number
AU4880901A
AU4880901A AU4880901A AU4880901A AU4880901A AU 4880901 A AU4880901 A AU 4880901A AU 4880901 A AU4880901 A AU 4880901A AU 4880901 A AU4880901 A AU 4880901A AU 4880901 A AU4880901 A AU 4880901A
Authority
AU
Australia
Prior art keywords
igf
dnas
family polypeptides
novel insulin
relaxin family
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU4880901A
Other languages
English (en)
Inventor
Yasuaki Itoh
Nobuhiro Suzuki
Kazunori Nishi
Hideki Kizawa
Masataka Harada
Kazuhiro Ogi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU4880901A publication Critical patent/AU4880901A/xx
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/64—Relaxins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/62—Insulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/64—Relaxins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
AU4880901A 2000-04-21 2001-04-20 Novel insulin/igf/relaxin family polypeptides and dnas thereof Pending AU4880901A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000126340 2000-04-21
JP2000205587 2000-07-03
JP2000247962 2000-08-10
JP2000395050 2000-12-22
PCT/JP2001/003399 WO2001081562A1 (en) 2000-04-21 2001-04-20 Novel insulin/igf/relaxin family polypeptides and dnas thereof

Publications (1)

Publication Number Publication Date
AU4880901A true AU4880901A (en) 2001-11-07

Family

ID=27481250

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001248809A Ceased AU2001248809B2 (en) 2000-04-21 2001-04-20 Novel insulin/IGF/relaxin family polypeptides and DNAs thereof
AU4880901A Pending AU4880901A (en) 2000-04-21 2001-04-20 Novel insulin/igf/relaxin family polypeptides and dnas thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2001248809A Ceased AU2001248809B2 (en) 2000-04-21 2001-04-20 Novel insulin/IGF/relaxin family polypeptides and DNAs thereof

Country Status (8)

Country Link
US (2) US7049403B2 (enExample)
EP (1) EP1283260A4 (enExample)
JP (1) JP4841054B2 (enExample)
KR (1) KR20020093053A (enExample)
CN (1) CN1633498A (enExample)
AU (2) AU2001248809B2 (enExample)
CA (1) CA2406855A1 (enExample)
WO (1) WO2001081562A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL154725A (en) * 2000-09-13 2003-12-23 Smithkline Beecham Corp Polynucleotides encoding secreted polypeptides
AUPR814401A0 (en) * 2001-10-08 2001-11-01 Howard Florey Institute Of Experimental Physiology And Medicine Human 3 relaxin
US20050074814A1 (en) * 2003-03-04 2005-04-07 Jingcai Chen Relaxin3-GPCR135 complexes and their production and use
KR100878959B1 (ko) 2004-02-09 2009-01-19 에자이 알앤드디 매니지먼트 가부시키가이샤 스크리닝 방법
JP2008512091A (ja) * 2004-08-25 2008-04-24 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ リラキシンキメラポリペプチドならびにそれらの製造法および使用
ATE549351T1 (de) * 2007-01-30 2012-03-15 Janssen Pharmaceutica Nv Chimärer peptidantagonist für gpcr135 oder gpcr142
US20100161366A1 (en) * 2008-12-19 2010-06-24 Achim Clemens Product requirement specification in production model
US9767495B2 (en) * 2008-12-19 2017-09-19 Sap Se Different sales and planning product options
CN116773828B (zh) * 2023-08-21 2023-10-31 成都大熊猫繁育研究基地 一种大熊猫rln3酶联免疫检测方法及单克隆抗体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0470976B1 (en) * 1989-05-04 1993-03-31 Genentech, Inc. Processes and compositions for the isolation of human relaxin
JP2001517444A (ja) 1997-09-24 2001-10-09 ジェネンテック・インコーポレーテッド インスリン様ポリペプチドとその使用
ZA200102380B (en) 1998-10-13 2002-03-22 Genentech Inc Methods and compositions for inhibiting neoplastic cell growth.
CA2347835A1 (en) * 1998-12-01 2000-06-08 Genentech, Inc. Promotion or inhibition of angiogenesis and cardiovascularization
WO2000047776A2 (en) 1999-02-12 2000-08-17 Zymogenetics, Inc. Insulin-family homolog localized to chromosome 1
EP1294887A1 (en) * 2000-03-10 2003-03-26 ZymoGenetics, Inc. Insulin homolog polypeptide zins4
US20020012967A1 (en) * 2000-03-10 2002-01-31 Holloway James L. Insulin homolog polypeptide zins4
IL154725A (en) * 2000-09-13 2003-12-23 Smithkline Beecham Corp Polynucleotides encoding secreted polypeptides

Also Published As

Publication number Publication date
US20030158381A1 (en) 2003-08-21
CN1633498A (zh) 2005-06-29
AU2001248809B2 (en) 2005-05-19
JP4841054B2 (ja) 2011-12-21
US7049403B2 (en) 2006-05-23
EP1283260A4 (en) 2004-08-18
JP2002345468A (ja) 2002-12-03
WO2001081562A1 (en) 2001-11-01
US20060073567A1 (en) 2006-04-06
CA2406855A1 (en) 2001-11-01
EP1283260A1 (en) 2003-02-12
US7410641B2 (en) 2008-08-12
KR20020093053A (ko) 2002-12-12

Similar Documents

Publication Publication Date Title
AU2001234944A8 (en) Novel nucleic acids and polypeptides
PL366331A1 (en) Receptor nucleic acids and polypeptides
IL168049A0 (en) Interferon- alpha polypeptides and conjugates
IL153568A (en) Novel polypeptides and polynucleotides
AU2002256461A8 (en) Polypeptides and nucleic acids associated with cancer
AU4880901A (en) Novel insulin/igf/relaxin family polypeptides and dnas thereof
AU2001248809A1 (en) Novel insulin/IGF/relaxin family polypeptides and DNAs thereof
HUP0400976A3 (en) Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptides
EP1186615A4 (en) PROTEIN AND DNA OF THIS PROTEIN
IL131707A0 (en) Acetylcholinesterase-derived peptides and uses thereof
GB9918155D0 (en) Proteins and peptides
IL137493A0 (en) Svph3-13 and spvh3-17 dna and polypeptides
IL152011A0 (en) Type ii gonadotropin-releasing hormone and polynucleotides encoding therefor
IL161544A0 (en) Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides
AU7005801A (en) Gp354 nucleic acids and polypeptides
AU2001263005A8 (en) Novel nucleic acids and polypeptides
IL143769A0 (en) Metalloproteinase-disintegrin family members: svph dnas and polypeptides
AU2001294267A1 (en) Survivin-like polypeptides and dnas thereof
AU7298201A (en) Gp286 nucleic acids and polypeptides
AU2001274563A1 (en) Novel polypeptide and its dna
AU2002227496A8 (en) Polynucleotides and polypeptides
HUP0300489A3 (en) Novel protein and gene encoding the same
IL133875A0 (en) Protein binding parathyroid hormone nucleotide sequences and uses thereof
GB0018307D0 (en) Polypeptides
EP1409523A4 (en) PANCAM NUCLEIC ACIDS AND POLYPEPTIDES